Követés
András Gézsi
András Gézsi
Department of Measurement and Information Systems, Budapest University of Technology and Economics
E-mail megerősítve itt: mit.bme.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Systems biology approaches to investigating the roles of extracellular vesicles in human diseases
A Gézsi, Á Kovács, T Visnovitz, EI Buzás
Experimental & molecular medicine 51 (3), 1-11, 2019
692019
Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance
O Lautner-Csorba, A Gézsi, ÁF Semsei, P Antal, DJ Erdélyi, G Schermann, ...
BMC medical genomics 5, 1-15, 2012
632012
Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance
I Ungvári, G Hullám, P Antal, PS Kiszel, A Gézsi, É Hadadi, V Virág, ...
PLoS One 7 (3), e33573, 2012
632012
Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis
O Lautner-Csorba, A Gezsi, DJ Erdelyi, G Hullam, P Antal, AF Semsei, ...
PloS one 8 (8), e69843, 2013
552013
Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion
NÁ Varga, K Pentelényi, P Balicza, A Gézsi, V Reményi, V Hársfalvi, ...
Behavioral and Brain Functions 14, 1-14, 2018
512018
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ...
Oncotarget 8 (6), 9388, 2017
462017
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
JC Sági, B Egyed, A Kelemen, N Kutszegi, M Hegyi, A Gézsi, ...
BMC cancer 18, 1-14, 2018
422018
HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
N Kutszegi, X Yang, A Gézsi, G Schermann, DJ Erdélyi, ÁF Semsei, ...
haematologica 102 (9), 1578, 2017
372017
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
A Rzepiel, N Kutszegi, A Gézsi, JC Sági, B Egyed, G Péter, H Butz, ...
Journal of translational medicine 17, 1-16, 2019
302019
VariantMetaCaller: automated fusion of variant calling pipelines for quantitative, precision-based filtering
A Gézsi, B Bolgár, P Marx, P Sarkozy, C Szalai, P Antal
BMC genomics 16, 1-15, 2015
282015
Accelerated clearance alone explains ultra‐large multimers in von Willebrand disease Vicenza
A Gézsi, U Budde, I Deák, E Nagy, A Mohl, Á Schlammadinger, Z Boda, ...
Journal of Thrombosis and Haemostasis 8 (6), 1273-1280, 2010
272010
Learning Complex Bayesian Network Features for Classification.
P Antal, A Gézsi, G Hullám, A Millinghoffer
Probabilistic Graphical Models, 9-16, 2006
272006
Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology
A Zeöld, GO Sándor, A Kiss, AÁ Soós, T Tölgyes, A Bursics, Á Szűcs, ...
Cellular and Molecular Life Sciences 78, 3005-3020, 2021
252021
Investigation of the possible role of the Hippo/YAP1 pathway in asthma and allergy
LE Fodor, A Gézsi, ldikó Ungvári, ÁF Semsei, Z Gál, A Nagy, G Gálffy, ...
Allergy, Asthma & Immunology Research 9 (3), 247-256, 2017
252017
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia
B Egyed, N Kutszegi, JC Sági, A Gézsi, A Rzepiel, T Visnovitz, P Lőrincz, ...
Journal of Translational Medicine 18, 1-12, 2020
242020
Comprehensive analysis of rare variants of 101 autism-linked genes in a Hungarian cohort of autism spectrum disorder patients
P Balicza, NÁ Varga, B Bolgár, K Pentelényi, R Bencsik, A Gál, A Gézsi, ...
Frontiers in genetics 10, 434, 2019
212019
Efficacy of vemurafenib treatment in 43 metastatic melanoma patients with BRAF mutation. Single-institute retrospective analysis, early real-life survival data
K Czirbesz, E Gorka, T Balatoni, G Panczel, K Melegh, P Kovacs, A Gezsi, ...
Pathology & Oncology Research 25, 45-50, 2019
212019
NKX2-1 new mutation associated with myoclonus, dystonia, and pituitary involvement
P Balicza, Z Grosz, V Molnár, A Illés, D Csabán, A Gézsi, L Dézsi, ...
Frontiers in Genetics 9, 335, 2018
212018
Pharmacogenetics of anthracyclines
JC Sági, N Kutszegi, A Kelemen, LE Fodor, A Gézsi, GT Kovács, ...
Pharmacogenomics 17 (9), 1075-1087, 2016
212016
Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
Z Gál, A Gézsi, ÁF Semsei, A Nagy, M Sultész, Z Csoma, L Tamási, ...
Journal of translational medicine 18, 1-15, 2020
202020
Subgroups of paediatric acute lymphoblastic leukaemia might differ significantly in genetic predisposition to asparaginase hypersensitivity
N Kutszegi, ÁF Semsei, A Gézsi, JC Sági, V Nagy, K Csordas, Z Jakab, ...
PloS one 10 (10), e0140136, 2015
192015
Novel genes in human asthma based on a mouse model of allergic airway inflammation and human investigations
G Temesi, V Virág, É Hadadi, I Ungvári, LE Fodor, A Bikov, A Nagy, ...
Allergy, asthma & immunology research 6 (6), 496, 2014
192014
Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
Z Gál, A Gézsi, É Pállinger, T Visnovitz, A Nagy, A Kiss, M Sultész, ...
Scientific Reports 10 (1), 4320, 2020
182020
In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia
A Gézsi, O Lautner-Csorba, DJ Erdélyi, G Hullám, P Antal, ÁF Semsei, ...
The pharmacogenomics journal 15 (3), 241-247, 2015
162015
Bayesian, systems-based, multilevel analysis of associations for complex phenotypes: from interpretation to decisions
P Antal, A Millinghoffer, G Hullám, G Hajós, P Sárközy, A Gézsi, C Szalai, ...
Probabilistic Graphical Models for Genetics, Genomics, and Postgenomics …, 2014
152014
Dabrafenib therapy in 30 patients with melanoma metastatic to the brain: a single-centre controlled retrospective study in Hungary
E Gorka, D Fabó, A Gézsi, K Czirbesz, I Fedorcsák, G Liszkay
Pathology & Oncology Research 24, 401-406, 2018
142018
Prevalence and characterization of severe asthma in Hungary
Z Csoma, Z Gál, A Gézsi, I Herjavecz, C Szalai
Scientific Reports 10 (1), 9274, 2020
112020
Distance from primary tumor is the strongest predictor for early onset of brain metastases in melanoma
E Gorka, D Fabo, A Gezsi, K Czirbesz, G Liszkay
Anticancer Research 36 (6), 3065-3069, 2016
112016
The role of genetic testing in the clinical practice and research of early-onset parkinsonian disorders in a hungarian cohort: Increasing challenge in genetic counselling …
A Illés, D Csabán, Z Grosz, P Balicza, A Gézsi, V Molnár, R Bencsik, A Gál, ...
Frontiers in genetics 10, 469071, 2019
102019
“Does happiness help healing?” Immune response of hospitalized children may change during visits of the Smiling Hospital Foundation’s Artists
A Béres, Z Lelovics, P Antal, G Hajós, A Gézsi, Á Czéh, E Lantos, T Major
Orvosi hetilap 152 (43), 1739-1744, 2011
92011
Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
Z Gál, A Gézsi, V Molnár, A Nagy, A Kiss, M Sultész, Z Csoma, L Tamási, ...
Frontiers in Genetics 11, 128, 2020
72020
Increased Clearance Explains the Ultra-Large Multimers in Von Willebrand Disease Type 2M Vicenza; Lessons from Recombinant VWF Vicenza and Modeling of Multimer Catabolism.
A Gézsi, G Balázsi, K Sallai, A Mohl, E Nagy, T Szabó, JE Sadler, I Bodó
Blood, The Journal of the American Society of Hematology 104 (11), 3669-3669, 2004
72004
Variation in the TEK gene is not associated with asthma but with allergic conjunctivitis
LE Fodor, A Gézsi, Z Gál, A Nagy, A Kiss, A Bikov, C Szalai
International Journal of Immunogenetics 45 (3), 102-108, 2018
52018
MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia
A Rzepiel, A Horváth, N Kutszegi, A Gézsi, JC Sági, L Almási, B Egyed, ...
Molecular and Cellular Probes 67, 101893, 2023
42023
Genetic landscape of early-onset dementia in Hungary
D Csaban, A Illes, TB Renata, P Balicza, K Pentelenyi, V Molnar, A Gezsi, ...
Neurological Sciences 43 (9), 5289-5300, 2022
42022
The role of the rare variants in the genes encoding the alpha-ketoglutarate dehydrogenase in Alzheimer’s disease
D Csaban, K Pentelenyi, R Toth-Bencsik, A Illes, Z Grosz, A Gezsi, ...
Life 11 (4), 321, 2021
42021
Hereditary Parkinson’s disease as a new clinical manifestation of the damaged POLG gene
A Illés, P Balicza, A Gál, K Pentelényi, D Csabán, A Gézsi, V Molnár, ...
Orvosi Hetilap 161 (20), 821-828, 2020
42020
From genomes to diaries: A 3-year prospective, real-life study of ragweed-specific sublingual immunotherapy
V Molnár, A Nagy, L Tamási, G Gálffy, R Böcskei, A Bikov, I Czaller, ...
Immunotherapy 9 (15), 1279-1294, 2017
42017
Two tagging single‐nucleotide polymorphisms to capture HLADRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity
N Kutszegi, A Gézsi, Á F. Semsei, J Müller, R Simon, ER Kovács, ...
British Journal of Clinical Pharmacology 87 (6), 2542-2548, 2021
32021
Decreased plasma level of cytokeratin 20 (KRT20) is indicative of the emergence and severity of acute GvHD irrespective to the type of organ involvement
N Lupsa, Á Szegedi, A Gézsi, Z Vuncs, T Masszi, G Mikala, P Reményi, ...
Biomedicines 10 (3), 519, 2022
22022
Hungarian genomic data warehouse supporting the healthy ageing research
V Várhegyi, V Molnár, A Gézsi, P Sárközy, P Antal, MJ Molnár
Orvosi Hetilap 162 (27), 1079-1088, 2021
22021
Pharmacogenetics of the central nervous system—toxicity and relapse affecting the cns in pediatric acute lymphoblastic leukemia
JC Sági, A Gézsi, B Egyed, Z Jakab, N Benedek, A Attarbaschi, S Köhrer, ...
Cancers 13 (10), 2333, 2021
22021
Corrigendum: Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
Z Gál, A Gézsi, V Molnár, A Nagy, A Kiss, M Sultész, Z Csoma, L Tamási, ...
Frontiers in Genetics 11, 702, 2020
22020
Significance of whole exome sequencing in the diagnostics of rare neurological diseases-own experiences through a case presenting with ataxia
P Balicza, Z Grosz, R Bencsik, A Illés, A Gál, A Gézsi, MJ Molnár
Orvosi Hetilap 159 (28), 1163-1169, 2018
22018
Monitoring the potential role of circulating miR-181b-5p in minimal residual disease in paediatric acute lymphoblastic leukaemia
N Kutszegi, A Rzepiel, A Gézsi, M Papp, B Egyed, H Butz, JC Csányi, ...
Journal of Extracellular Vesicles 7, 241-241, 2018
22018
Constructing a Quantitative Fusion Layer over the Semantic Level for Scalable Inference
A Gezsi, B Bruncsics, G Guta, P Antal
Bioinformatics and Biomedical Engineering: 6th International Work-Conference …, 2018
22018
MicroRNA Prioritization based on Target Profile Similarities.
P Marx, B Bolgár, A Gézsi, A Gulyás-Kovács, P Antal
BIOINFORMATICS, 278-285, 2014
22014
Bioinformatika: molekuláris méréstechnikától az orvosi döntéstámogatásig
P Antal, G Hullám, A Millinghoffer, G Hajós, P Marx, Á Arany, B Bolgár, ...
Budapesti Műszaki Egyetem, 2014
22014
Bayesian systems-based genetic association analysis with effect strength estimation and omic wide interpretation: a case study in rheumatoid arthritis
G Hullám, A Gézsi, A Millinghoffer, P Sárközy, B Bolgár, SK Srivastava, ...
Arthritis Research: Methods and Protocols, 143-176, 2014
22014
Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications
P Balicza, A Gezsi, M Fedor, JC Sagi, A Gal, NA Varga, MJ Molnar
Frontiers in Psychiatry 14, 1301272, 2024
12024
Education of hand hygiene in children during the pandemia
HJ Feith, Á Lehotsky, A Gézsi, JÁ Lukács, E Gradvohl, A Falus
Orvosi Hetilap 162 (46), 1842-1847, 2021
12021
Effectiveness of a Hungarian peer education handwashing programme in primary and secondary schools
ZS Molnár, L Varga, G Gyenes, Á Lehotsky, E Gradvohl, ÁJ Lukács, ...
Developments in Health Sciences 3 (3), 58-64, 2021
12021
ALL-074: exosomal micrornas as minimal residual disease biomarker candidates in childhood acute lymphoblastic leukemia
A Rzepiel, B Egyed, A Gézsi, JC Sági, ÁF Semsei, C Szalai, DJ Erdélyi
Clinical Lymphoma Myeloma and Leukemia 20, S162, 2020
12020
Az örökletes Parkinson-kór mint a POLG-gén károsodásának új klinikai megjelenési formája
A Illés, P Balicza, A Gál, K Pentelényi, D Csabán, A Gézsi, V Molnár, ...
Orvosi Hetilap 161 (20), 821-828, 2020
12020
Orvosok és ápolók véleménye a szülõi döntési kompetenciákról a NIC osztályokon.
J Feith Helga, EZ Sallai, Z Soósné Kiss, A Kovács, M Szabó, A Gézsi, ...
Gyermekgyógyászat 70 (6), 2019
12019
The impact of ethical and legal decision-making In neonatal intensive care on psychosocial wellbeing of the health care professionals
HJ Feith, KZ Soósné, J Pilling, A Kovács, M Szabó, M Cuttini, I Berbik, ...
12019
Unknown, Uncertain, Untrue: Challenges in Inference Using Semantic Life Science Data
B Bruncsics, A Gézsi, P Antal
25th Mini-Symposium, 12-15, 2018
12018
Our experiences with the combination therapy of vemurafenib and cobimetinib in metastatic melanoma patient.
E Gorka, K Czirbesz, A Gézsi, G Liszkay
Bőrgyógyászati és Venerológiai Szemle 93 (4), 168-171, 2017
12017
Genetikai variánskivonatoló munkafolyamatok automatikus fúziója és a bayesi relevanciaelemzés alkalmazása jelölt gén asszociációs vizsgálatokban
A Gézsi
12017
„A mosoly is gyógyít?” Beteg gyermekek immunválasza is változhat a Mosolygó Kórház Alapítvány művészeinek látogatásakor=“Does happiness help healing?” Immune response of …
A Béres, Z Lelovics, P Antal, G Hajós, A Gézsi, Á Czéh, E Lantos, T Major
Orvosi Hetilap 152 (43), 1739-1744, 2011
12011
GNN4DM: A Graph Neural Network-based method to identify overlapping functional disease modules
A Gézsi, P Antal
bioRxiv, 2024.01. 30.578064, 2024
2024
Impact of gene-by-trauma interaction in MDD-related multimorbidity clusters
S Bonk, N Eszlari, K Kirchner, A Gezsi, L Garvert, M Koukkanen, I Cano, ...
2023
Unique genetic and risk-factor profiles in multimorbidity clusters of depression-related disease trajectories from a study of 1.2 million subjects
G Juhasz, A Gezsi, S Van der Auwera, H Mäkinen, N Eszlari, G Hullam, ...
2023
Ép testben ép lélek: új megközelítés a depresszió heterogenitásának megértésére.| A sound mind in a sound body: a novel concept unravelling heterogeneity of depression
G Hullam, I Cano, M Koukkanen, Z Gal, G Juhasz, X Gonda, ...
Neuropsychopharmacologia Hungarica 25 (DZNE-2024-00034), 183-193, 2023
2023
A sound mind in a sound body: a novel concept unravelling heterogeneity of depression
G JUHASZ
Neuropsychopharmacol Hung 25 (4), 183-193, 2023
2023
Multicentric validation of a Multimorbidity Adjusted Disability Score to stratify depression-related risks using temporal disease maps
R Gonzalez-Colom, K Mitra, E Vela, A Gezsi, T Paajanen, Z Gal, G Hullam, ...
medRxiv, 2023.09. 04.23295005, 2023
2023
Gene co-expression analyses of health (span) across multiple species
S Möller, N Saul, E Projahn, I Barrantes, A Gézsi, M Walter, P Antal, ...
NAR Genomics and Bioinformatics 4 (4), lqac083, 2022
2022
Analysis of the most common nuclear genome encoded mitochondrial gene in Hungarian patients with adult-onset mitochondrial disorders
F Szabo, Z Grosz, A Gezsi, A Suveges, IJ Jimoh, H Zeke, A Gal, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 286-286, 2022
2022
Establishing the Hungarian Genomic Data Warehouse for studying the genetics of healthy ageing and longevity
V Varhegyi, V Molnar, A Gezsi, P Sarkozy, P Antal, MJ Molnar
EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 529-529, 2022
2022
Comparing depression comorbidity networks of different age groups
G Hullám, T Nagy, A Gézsi, P Antal, G Juhász
Neuroscience Applied 1, 100173, 2022
2022
Életvégi döntésekkel kapcsolatos attitűdök a neonatológiai intenzív ellátásban dolgozók körében–jogi szempontok a döntések hátterében= Attitudes towards end-of-life decisions …
HJ Feith, EZ Sallai, Z Soósné Kiss, A Gézsi, E Gradvohl, AK Kovács, ...
LEGE ARTIS MEDICINAE 32 (6-7), 289-297, 2022
2022
Novel Liquid Biopsy Markers of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia
B Egyed, N Kutszegi, JC Sagi, A Gezsi, A Rzepiel, T Visnovitz, C Szalai, ...
PEDIATRIC BLOOD & CANCER 68, S175-S176, 2021
2021
A Magyar Genomikai Egészségtárház az egészséges hosszú élet kutatásának szolgálatában
V Várhegyi, V Molnár, A Gézsi, P Sárközy, P Antal, MJ Molnár
Orvosi Hetilap 162 (27), 1079-1088, 2021
2021
Egy ferencvárosi gyermekkórház
J Sólyom
2021
Genetic characterization of Hungarian patients with early onset dementia
D Csaban, R Bencsik, A Illes, V Molnar, P Balicza, A Gezsi, Z Grosz, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 385-385, 2020
2020
ALL-198: Pharmacogenetic Study on Central Nervous System Relapse Among Patients with Pediatric Acute Lymphoblastic Leukemia in Hungary
JC Sagi, A Artner, B Egyed, A Rzepiel, N Kutszegi, A Gezsi, L Tiszlavicz, ...
Clinical Lymphoma Myeloma and Leukemia 20, S164, 2020
2020
Author Correction: Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
Z Gál, A Gézsi, T Visnovitz, A Nagy, A Kiss, M Sultész, G Gálffy, C Szalai
Scientific Reports 10, 2020
2020
New Liquid Biopsy Markers for the Detection of Central Nervous System Involvement in Childhood Acute Leukemia
B Egyed, JC Sági, N Kutszegi, A Gézsi, A Rzepiel, C Szalai, GT Kovács, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S187-S188, 2019
2019
Circulating microRNAs as Potential Minimal Residual Disease Biomarkers in Pediatric Acute Lymphoblastic Leukemia
A Rzepiel, N Kutszegi, B Egyed, A Gézsi, JS Csányi, ÁF Semsei, C Szalai, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S193, 2019
2019
Pharmacogenetic Study of the Central Nervous System in Pediatric Acute Lymphoblastic Leukemia
JC Sagi, A Artner, A Kelemen, B Egyed, A Rzepiel, N Kutszegi, A Gezsi, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S189-S190, 2019
2019
Sequential approach to identify disease causing variants in patients with mitochondrial dysfunction of a Hungarian cohort
V Molnar, A Gezsi, A Illes, P Balicza, B Berta, D Csaban, IJ Jimoh, A Gal, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 27, 191-192, 2019
2019
Burden test of selected autism-associated genes in a Hungarian cohort
P Balicza, NA Varga, K Pentelenyi, R Bencsik, A Gal, C Prekop, V Molnar, ...
EUROPEAN JOURNAL OF NEUROLOGY 26, 208-208, 2019
2019
Coexistance of mutations and genetic risk factors in early onset Parkinson's disease challenge the genetic counseling
Z Grosz, A Illes, P Balicza, D Csaban, A Gezsi, V Molnar, A Gal, ...
EUROPEAN JOURNAL OF NEUROLOGY 26, 697-697, 2019
2019
Altered mitochondrial dynamics due to DNM2 mutations
A Gal, S Naghdi, D Weaver, A Gezsi, MJ Molnar, G Hajnóczky
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859, e88, 2018
2018
A teljesexom-szekvenálás jelentősége a ritka neurológiai betegségek diagnosztikájában–saját tapasztalatok egy ataxiás eset kapcsán
P Balicza, Z Grosz, R Bencsik, A Illés, A Gál, A Gézsi, MJ Molnár
Orvosi Hetilap 159 (28), 1163-1169, 2018
2018
Systems biology analysis reveals that several common diseases are associated with genes involved in the biogenesis of extracellular vesicles
A Gézsi, A Varga, EI Buzás
Journal of Extracellular Vesicles 7, 255-255, 2018
2018
Circulating microRNAs as potential biomarkers of pediatric acute lymphoblastic leukemia
A Rzepiel, N Kutszegi, B Egyed, A Gézsi, JC Csányi, ÁF Semsei, G Nyírő, ...
Journal of Extracellular Vesicles 7, 148-148, 2018
2018
Targeted next-generation sequencing (NGS) as a diagnostic tool in syndromic autism spectrum disorder (ASD)
NA Varga, K Pentelenyi, P Balicza, R Bencsik, A Illes, A Gezsi, C Prekop, ...
EUROPEAN JOURNAL OF NEUROLOGY 24, 424-424, 2017
2017
Single Center Retrospective Comparison of the Targeted Combination Therapies in Melanoma Patients
E Gorka, A Gézsi, G Liszkay
2017
Bioinformatika laboratórium: molekuláris méréstechnikától az orvosi döntéstámogatásig
P Antal, G Hullám, A Millinghoffer, G Hajós, Á Arany, B Bolgár, A Gézsi, ...
2014
Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute
O Lautner-Csorba, A Gézsi, DJ Erdélyi, G Hullám, P Antal
2013
1158 Candidate Gene Association Study in Childhood Acute Lymphoblastic Leukemia
O Lautner-Csorba, AF Semsei, A Gezsi, N Kutszegi, A Falus, C Szalai
european journal of cancer, S278, 2012
2012
SYSTEMS BIOLOGY: PERSPECTIVES IN PERSONALIZED MEDICINE
A Falus, P Antal, A Gezsi, K Eder, D Erdelyi, A Semsei, C Szalai
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 2-2, 2011
2011
Multivariate Bayesian Analysis of Genome-Wide Association Studies
A Gézsi
18th PhD Mini-Symposium, 28, 2011
2011
On the applicability of Bayesian univariate methods as filters in complex GWAS analysis
P Antal, A Gézsi, A Millinghoffer, G Hajós, C Szalai, A Falus
Machine Learning in Systems Biology, 91, 2010
2010
VWFWizard–a software program simulating VWF multimer assembly, secretion, cleavage and clearance Short title: VWFWizard–software description and validation
A Gézsi, U Budde, I Deák, E Nagy, A Mohl, Á Schlammadinger, Z Boda, ...
SUPPLEMENTARY RESULTS, FIGURES AND TABLES OF: VARIANTMETACALLER: AUTOMATED FUSION OF VARIANT CALLING PIPELINES FOR QUANTITATIVE, PRECISION-BASED FILTERING
A GÉZSI, B BOLGAR, P MARX, P SARKOZY, C SZALAI, P ANTAL
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–97